Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1971 2
1981 1
1982 2
1983 1
1984 2
1985 2
1986 3
1987 1
1988 1
1989 3
1990 4
1991 6
1992 2
1993 3
1994 2
1995 2
1996 1
1997 2
2000 3
2001 4
2002 3
2003 3
2004 2
2005 4
2006 4
2007 5
2008 3
2009 4
2010 7
2011 7
2012 12
2013 10
2014 13
2015 14
2016 11
2017 13
2018 16
2019 13
2020 7
2021 18
2022 14
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Results by year

Filters applied: . Clear all
Page 1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
A sandPIT for Salmonella to play with efferosomes.
Morrison R, Luk CH, Gutierrez MG. Morrison R, et al. Among authors: luk ch. Cell Host Microbe. 2022 Feb 9;30(2):141-143. doi: 10.1016/j.chom.2022.01.008. Cell Host Microbe. 2022. PMID: 35143763 Free article.
Dual Role of Caspase 8 in Adipocyte Apoptosis and Metabolic Inflammation.
Luk CT, Chan CK, Chiu F, Shi SY, Misra PS, Li YZ, Pollock-Tahiri E, Schroer SA, Desai HR, Sivasubramaniyam T, Cai EP, Krishnamurthy M, Han DJ, Chowdhury A, Aslam R, Yuen DA, Hakem A, Hakem R, Woo M. Luk CT, et al. Diabetes. 2023 Dec 1;72(12):1751-1765. doi: 10.2337/db22-1033. Diabetes. 2023. PMID: 37699387
Outcomes of adolescents with acute lymphoblastic leukaemia.
Feng J, Cheng FWT, Chiang AKS, Lam GKS, Chow TTW, Ha SY, Luk CW, Li CH, Ling SC, Yau PW, Ho KKH, Leung AWK, Chan NPH, Ng MHL, Li CK. Feng J, et al. Among authors: luk cw. Hong Kong Med J. 2022 Jun;28(3):204-214. doi: 10.12809/hkmj208914. Epub 2022 Jun 14. Hong Kong Med J. 2022. PMID: 35697524 Free article.
221 results